As of June 2024 Ampio Pharmaceuticals has a market cap of $0.23 Million. This makes Ampio Pharmaceuticals the world's 8424th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.23 M | -86.02% |
2023 | $1.7 M | -49.79% |
2022 | $3.39 M | -97.38% |
2021 | $0.12 B | -56% |
2020 | $0.29 B | 218.13% |
2019 | $92.48 M | 111.17% |
2018 | $43.79 M | -85.83% |
2017 | $0.30 B | 500.47% |
2016 | $51.47 M | -71.72% |
2015 | $0.18 B | 2.09% |
2014 | $0.17 B | -40.56% |
2013 | $0.29 B | 125.74% |
2012 | $0.13 B | 8.02% |
2011 | $0.12 B | 199.58% |
2010 | $41.05 M | 2844.04% |
2009 | $1.39 M | 0% |
2008 | $1.39 M |
On Jun 1st, 2024 the market cap of Ampio Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.98 B | 148,049,716.49% | ๐บ๐ธ USA |
Pfizer PFE | $162.40 B | 68,115,435.99% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $177.77 B | 74,561,204.29% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $107.99 B | 45,297,122.92% | ๐บ๐ธ USA |
Rigel Pharmaceuticals RIGL | $0.17 B | 71,835.40% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.45 B | 192,384.50% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | $0.75 B | 315,980.68% | ๐บ๐ธ USA |